ACEi, angiotensin antagonists, diuretics Flashcards
RAAS pathway
where is renin produced
in the juxtaglomerular cells in kidney
what causes renin release
drop in BP in pre-glomerular arteries (systolic <90 mmHg)
low NaCl in kidney’s distal tubule
increased SNS activity (beta1)
where is angiotensinogen produced
liver
where is angiotensin converting enzyme (ACE) produced
kidney
what does angiotensin II cause
aldosterone secretion
vasoconstriction
what does angiotensin II mediated vasoconstriction cause
increased peripheral vascular resistance
–> increased BP
what does angiotensin II mediated aldosterone secretion cause
increased retention of Na and water –> increased BP
where does renin cleave angiotensinogen
between Leu-Val aa
where does ACE cleave angiotensin I
between Phe-His aa
where does aminopeptidase cleave angiotensin II
between Asp-Arg
what is the name of renin inhibitor drug
Aliskiren
aliskiren moa
direct inhibitor renin
decreases formation of angiotensin I from angiotensinogen
aliskiren clinical use
not 1st line tx for htn
aliskiren effect
drops BP bc it inhibits renin
aliskiren problems
do not use in pregnant and nursing mothers
what is common identifying factor of ACEi
all ACEi ends in -pril
what are the sulfahydryl-containing ACEi structurally related to Captopril
fentiapril, pivalopril, zofenopril, alacepril
what are the dicarboxyl-containing ACEi structurally related to Enalapril
lisinopril, benazepril, quinapril, moexipril, ramipril, trandolapril, perindopril, spirapril, pentopril, cilazapril
what are the phosphorous-containing ACEi
Fosinopril
ACEi action
inhibits angiotensin converting enzyme
ACEi effects
reduces vasoconstriction caused by angiotensin II
reduce Na and Cl retention caused by aldosterone
reduce total peripheral resistance
reduces myocardial mitogenic activity
ACEi clinical use
1st line tx for htn, hf
ACEi and ARBs in different races
particular useful in whites but not african americans as monotherapy for htn but appropriate for hf